---
id: antimicrobials_tmp-smx-hyperkalemia_022
category: antimicrobials
tags: [antimicrobials, tmp-smx, hyperkalemia, adverse-effects, renal]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## TMP-SMX-Induced Hyperkalemia

**Q:** What is the mechanism of TMP-SMX-induced hyperkalemia, and what are the major risk factors?

**A:**

**Mechanism:**
- **Trimethoprim** acts like amiloride (potassium-sparing diuretic)
- Blocks **epithelial sodium channels (ENaC)** in the distal nephron
- Reduces transepithelial voltage → **inhibits K⁺ secretion**
- Effect is **dose-dependent** and typically occurs within days

**Major Risk Factors:**
1. **Renal insufficiency** (STRONGEST predictor)
   - eGFR <60: 3x ↑ risk
   - eGFR <30: Risk difference 1.45% vs amoxicillin
   - Risk increases progressively with declining GFR
2. **RAAS inhibitors** (ACE-I, ARBs, aldosterone antagonists)
3. **High-dose TMP-SMX** (especially for PCP treatment)
4. **Other K⁺-sparing drugs** (amiloride, spironolactone, triamterene)
5. **Diabetes mellitus** (hyporeninemic hypoaldosteronism)
6. **Age >65 years**

**Clinical Significance:**
- Can cause **severe hyperkalemia and sudden death** (even at low doses)
- 3-fold higher risk of hospital encounter for hyperkalemia vs amoxicillin
- Monitor K⁺ especially in high-risk patients (check within 3-7 days)

**Mnemonic: "RADD K+" for risk factors**
- **R**enal insufficiency
- **A**CE-I/ARBs
- **D**iabetes
- **D**ose (high-dose)
- **K⁺** supplements/sparing agents

| **eGFR (mL/min/1.73m²)** | **Risk Difference vs Amoxicillin** |
|--------------------------|-------------------------------------|
| ≥60 | 0.12% |
| 45-59 | 0.42% |
| 30-44 | 0.85% |
| <30 | 1.45% |

**Media:** None

**Sources:** [Nephrology Dialysis Transplantation 2023], [AJKD 2011 - Older women cohort], [Karger Case Report 2023 - Life-threatening hyperkalemia], [CHEST 2023 - Digoxin toxicity case]
